journal article·2018-08

Sterilization of hydrogels for biomedical applications: A review

Raquel Galante, Terezinha J. A. Pinto, Rogério Colaço, Ana Paula Serro

Publisher page

Abstract

Abstract Despite the beneficial properties and outstanding potential of hydrogels for biomedical applications, several unmet challenges must be overcome, especially regarding to their known sensitivity to conventional sterilization methods. It is crucial for any biomaterial to withstand an efficient sterilization to obtain approval from regulatory organizations and to safely proceed to clinical trials. Sterility assurance minimizes the incidence of medical device‐related infections, which still constitute a major concern in health care. In this review, we provide a detailed and comprehensive description of the published work from the past decade regarding the effects of sterilization on different types of hydrogels for biomedical applications. Advances in hydrogel production methods with simultaneous sterilization are also reported. Terminal sterilization methods can induce negative or positive effects on several material properties (e.g., aspect, size, color, chemical structure, mechanical integrity, and biocompatibility). Due to the complexity of factors involved (e.g., material properties, drug stability, sterilization conditions, and parameters), it is important to note the virtual impossibility of predicting the outcome of sterilization methods to determine a set of universal rules. Each system requires case‐by‐case testing to select the most suitable, effective method that allows for the main properties to remain unaltered. The impact of sterilization methods on the intrinsic properties of these systems is understudied, and further research is needed. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2472–2492, 2018.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departamento de Farmácia Faculdade de Ciências Farmacêuticas, Universidade de São Paulo Butantã São Paulo Brazil

Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa Lisboa Portugal

Departamento de Engenharia Mecânica and IDMEC Instituto Superior Técnico, Universidade de Lisboa Lisboa Portugal

Centro de Investigação Interdisciplinar Egas Moniz, Instituto Superior de Ciências da Saúde Egas Moniz, Quinta da Granja, Monte de Caparica Caparica Portugal

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico · Fundação para a Ciência e a Tecnologia

References (100+)

Show source-provided references
1. 10.1038/185117a010.1038/185117a0 ↗
2. 10.1016/S0169-409X(01)00239-310.1016/S0169-409X(01)00239-3 ↗
3. 10.1002/adma.20050161210.1002/adma.200501612 ↗
4. 10.1016/j.eurpolymj.2014.11.02410.1016/j.eurpolymj.2014.11.024 ↗
5. 10.1016/S0939-6411(00)00090-410.1016/S0939-6411(00)00090-4 ↗
6. 10.1016/0142-9612(95)00307-X10.1016/0142-9612(95)00307-X ↗
7. 10.1016/j.jconrel.2014.03.05210.1016/j.jconrel.2014.03.052 ↗
8. 10.1016/j.mser.2015.04.00110.1016/j.mser.2015.04.001 ↗
9. 10.1016/j.progpolymsci.2012.09.00110.1016/j.progpolymsci.2012.09.001 ↗
10. Laverty G · 2012 · 79
11. 10.1002/bit.2310510.1002/bit.23105 ↗
12. 10.1039/C4TB00083H10.1039/C4TB00083H ↗
13. 10.1556/IMAS.6.2014.2.110.1556/IMAS.6.2014.2.1 ↗
14. Ratner BD · 2012
15. Nano drug delivery systems and gamma radiation sterilization
16. 10.1016/j.nano.2014.03.01710.1016/j.nano.2014.03.017 ↗
17. WilliamA.RutalaDJW HICPAC. Guideline for Disinfection and Sterilization in Healthcare Facilities;2008. p.158.
18. 5 EPE · 2005 · 445
19. Decontamination and sterilization
20. 10.1533/9780857096265.110.1533/9780857096265.1 ↗
21. Services USDoHaH (FDA) FaDA (CDER) CfDEaR (CBER) CfBEaR (ORA) OoRA. Guidance for Industry—Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice;2004.
22. 10.1007/978-3-642-59779-4_1010.1007/978-3-642-59779-4_10 ↗
23. 10.1002/jbm.b.1002010.1002/jbm.b.10020 ↗
24. 10.1016/j.biomaterials.2005.04.06310.1016/j.biomaterials.2005.04.063 ↗
25. 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.0.CO;2-A10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.0.CO;2-A ↗
26. 10.1359/jbmr.2001.16.11.208210.1359/jbmr.2001.16.11.2082 ↗
27. Standardization IOf. Sterilization of health care products— eneral requirements for characterization of a sterilizing agent and the development validation and routine control of a sterilization process for medical devices ISO 14937:2009(E);2009.
28. Roger WJ. · 2012 · 2010.1533/9780857096265.20 ↗
29. Brasil. Farmacopeia Brasileira volume1. Agência Nacional de Vigilância Sanitária. Brasília: Anvisa;2010. p.904.
30. Pinto TJA · 2015
31. 10.1201/978142002162210.1201/9781420021622 ↗
32. Sterilization of health care products – Radiation Part 1: Requirements for Development Validation and Routine Control of a Sterilization Process for Medical Devices Part 2: Establishing the Sterilization Dose Part 3: Guidance on Dosimetric Aspects ISO 11137 ISO Geneva;2006.
33. 10.4329/wjr.v8.i4.35510.4329/wjr.v8.i4.355 ↗
34. 10.5731/pdajpst.2014.0095510.5731/pdajpst.2014.00955 ↗
35. 10.1533/9780857096265.5610.1533/9780857096265.56 ↗
36. 10.1128/CMR.12.1.14710.1128/CMR.12.1.147 ↗
37. 10.1016/j.ajic.2006.10.01410.1016/j.ajic.2006.10.014 ↗
38. Standarization IOf. Sterilization of health‐care products—Ethylene oxide—Requirements for the development validation and routine control of a sterilization process for medical devices;2016.
39. McKeenLW.The Effect of Sterilization on Plastics and Elastomers. William Andrew Elselvier.2012. p.363.10.1016/B978-1-4557-2598-4.00013-7 ↗
40. Mendes GC · 2012 · 71
41. 10.1016/j.ajic.2015.10.03810.1016/j.ajic.2015.10.038 ↗
42. 10.3892/etm.2010.13610.3892/etm.2010.136 ↗
43. 10.1016/j.jfoodeng.2016.02.02610.1016/j.jfoodeng.2016.02.026 ↗
44. 10.1016/j.memsci.2008.07.04910.1016/j.memsci.2008.07.049 ↗
45. 10.1017/S146625231100001610.1017/S1466252311000016 ↗
46. Ducheyne P · 2015
47. 10.1371/journal.pone.012920510.1371/journal.pone.0129205 ↗
48. 10.1016/j.supflu.2005.05.00510.1016/j.supflu.2005.05.005 ↗
49. 10.1016/j.supflu.2013.08.01110.1016/j.supflu.2013.08.011 ↗
50. 10.1016/j.supflu.2010.02.00610.1016/j.supflu.2010.02.006 ↗
51. EPA US. Guidance Manual: Alternative Disinfectants and Oxidants – Chap. 3 “Ozone”. Washington D.C.: Office of Water;1999. pp21–24.
52. 10.1016/j.msec.2017.04.07310.1016/j.msec.2017.04.073 ↗
53. 10.1016/j.jmbbm.2015.08.02410.1016/j.jmbbm.2015.08.024 ↗
54. 10.1016/j.polymdegradstab.2009.10.00710.1016/j.polymdegradstab.2009.10.007 ↗
55. 10.1002/jbm.b.3285310.1002/jbm.b.32853 ↗
56. 10.1002/jbm.b.3292810.1002/jbm.b.32928 ↗
57. 10.1016/j.jmbbm.2012.09.01110.1016/j.jmbbm.2012.09.011 ↗
58. 10.1016/j.snb.2012.10.04010.1016/j.snb.2012.10.040 ↗
59. 10.1002/pol.1954.12014771110.1002/pol.1954.120147711 ↗
60. 10.1016/S0069-8040(08)70333-910.1016/S0069-8040(08)70333-9 ↗
61. 10.1016/S0069-8040(08)70336-410.1016/S0069-8040(08)70336-4 ↗
62. Ågren M. · 2016
63. 10.1002/adv.2154310.1002/adv.21543 ↗
64. 10.1016/j.triboint.2014.05.00110.1016/j.triboint.2014.05.001 ↗
65. 10.1016/j.supflu.2016.01.01410.1016/j.supflu.2016.01.014 ↗
66. 10.1002/bit.2310510.1002/bit.23105 ↗
67. 10.1002/jbm.a.3171710.1002/jbm.a.31717 ↗
68. 10.1002/bit.2198310.1002/bit.21983 ↗
69. 10.1016/j.biomaterials.2016.09.02010.1016/j.biomaterials.2016.09.020 ↗
70. 10.1016/j.polymertesting.2013.08.00610.1016/j.polymertesting.2013.08.006 ↗
71. 10.1177/088532821139850810.1177/0885328211398508 ↗
72. 10.1016/j.actbio.2009.05.03010.1016/j.actbio.2009.05.030 ↗
73. 10.1080/1083745060116659310.1080/10837450601166593 ↗
74. 10.1163/156856209X44945210.1163/156856209X449452 ↗
75. 10.1021/bm060157510.1021/bm0601575 ↗
76. 10.1016/j.supflu.2015.04.00610.1016/j.supflu.2015.04.006 ↗
77. 10.1002/jbm.b.3307010.1002/jbm.b.33070 ↗
78. 10.1016/j.jmbbm.2017.01.03810.1016/j.jmbbm.2017.01.038 ↗
79. 10.1016/j.polymdegradstab.2009.11.00110.1016/j.polymdegradstab.2009.11.001 ↗
80. 10.1002/term.161610.1002/term.1616 ↗
81. 10.1039/C6BM00478D10.1039/C6BM00478D ↗
82. 10.1016/j.actbio.2011.11.01510.1016/j.actbio.2011.11.015 ↗
83. 10.1002/term.151710.1002/term.1517 ↗
84. 10.1002/smll.20090100610.1002/smll.200901006 ↗
85. Effects of sterilization techniques on the PEGylated poly (γ‐benzyl‐L‐glutamate) (PBLG) nanoparticles
86. 10.1016/j.ejpb.2005.11.00710.1016/j.ejpb.2005.11.007 ↗
87. 10.1016/j.ijpharm.2015.01.02410.1016/j.ijpharm.2015.01.024 ↗
88. 10.1371/journal.pone.016886210.1371/journal.pone.0168862 ↗
89. 10.1016/j.matlet.2011.12.11610.1016/j.matlet.2011.12.116 ↗
90. 10.1016/j.polymer.2016.01.03010.1016/j.polymer.2016.01.030 ↗
91. 10.1016/S0969-806X(98)00319-310.1016/S0969-806X(98)00319-3 ↗
92. 10.1016/j.polymdegradstab.2017.01.00510.1016/j.polymdegradstab.2017.01.005 ↗
93. 10.1016/j.radphyschem.2013.05.05310.1016/j.radphyschem.2013.05.053 ↗
94. 10.1002/app.3348010.1002/app.33480 ↗
95. 10.1016/j.nimb.2007.09.00910.1016/j.nimb.2007.09.009 ↗
96. 10.1016/j.nimb.2006.11.10110.1016/j.nimb.2006.11.101 ↗
97. 10.1016/j.radphyschem.2012.02.02410.1016/j.radphyschem.2012.02.024 ↗
98. 10.1016/j.addr.2012.07.01510.1016/j.addr.2012.07.015 ↗
99. 10.1016/j.radphyschem.2007.06.00610.1016/j.radphyschem.2007.06.006 ↗
100. Hydrogel based Drug delivery systems: A review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials